| 2026 | Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry | EUROPEAN HEART JOURNAL |
| 2026 | Impact of Leadless Pacemaker Implantation Position on Subclinical Right Ventricular Perforation | PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY |
| 2026 | Efficacy and safety of direct oral anticoagulants for intermediate stroke risk in patients with atrial fibrillation (SINGLE-AF): Study design and protocol
| HEART RHYTHM O2 |
| 2026 | Associations Between Accelerometer-Measured 24-Hour Movement Behaviors and Cardiac Conduction Disease in the UK Biobank Cohort
| KOREAN CIRCULATION JOURNAL |
| 2026 | Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 Trial | JAMA CARDIOLOGY |
| 2026 | Injured cardiac targeting magnetic nanovesicles for mRNA treatment of myocardial infarction
| THERANOSTICS |
| 2026 | Association between non-ablated left atrial surface area and rhythm outcome in patients treated with cryoballoon and radiofrequency ablation
| HEART RHYTHM O2 |
| 2026 | Comprehensive risk factor analysis of sick sinus syndrome: a genetic, sociodemographic, clinical and laboratory investigation using the UK Biobank data | HEART |
| 2026 | Wearable device derived electrocardiographic age and its association with atrial fibrillation | NPJ DIGITAL MEDICINE(Nature partner journals digital medicine Digital medicine) |
| 2026 | Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity
| ANTIOXIDANTS |
| 2026 | Recent-onset atrial fibrillation: challenges and opportunities
| EUROPEAN HEART JOURNAL |
| 2025 | Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank study
| EUROPACE |
| 2025 | Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation-Reply | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2025 | Safety and Clinical Outcome of Subcutaneous Implantable Cardioverter-Defibrillators in an Asian Population: A Prospective Study | JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY |
| 2025 | Asia Pacific Heart Rhythm Society (APHRS) scientific statement on stroke prevention strategies in patients with device-detected atrial fibrillation: the 4S-DDAF approach
| LANCET REGIONAL HEALTH-WESTERN PACIFIC |
| 2025 | The optimal lookback period for estimating incidence and temporal trends in atrial fibrillation | HEART RHYTHM |
| 2025 | Safety and efficacy of an intrinsic antitachycardia pacing algorithm in patients from Japan and South Korea: results from a cardiac device registry in the Asia Pacific region
| JOURNAL OF MEDICAL ECONOMICS |
| 2025 | Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents | NEW ENGLAND JOURNAL OF MEDICINE |
| 2025 | Mapping and ablation outcomes of extra-pulmonary vein triggers in atrial fibrillation: single-centre retrospective study with consistent provocation protocol | EUROPACE |
| 2025 | Dynamic changes of artificial intelligence estimated electrocardiographic age and sex predicts recurrence after atrial fibrillation catheter ablation | EUROPACE |
| 2025 | Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation The ALONE-AF Randomized Clinical Trial | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2025 | Racial Differences in Bleeding Risks among Patients with Atrial Fibrillation: An Ecological Epidemiological Study Comparing Korea and UK Population
| THROMBOSIS AND HAEMOSTASIS |
| 2025 | Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial | JAMA CARDIOLOGY |
| 2025 | Real-World Effectiveness of Adaptive Left Ventricular-Only Pacing for Cardiac Resynchronization Therapy in Asian Population: Insights From the K-Adaptive CRT Study
| KOREAN CIRCULATION JOURNAL |
| 2025 | Racial differences and similarities in atrial fibrillation epidemiology and risk factors in UK Biobank and Korean NHIS-HEALS cohort studies | HEART RHYTHM |
| 2025 | Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial | CIRCULATION |
| 2025 | Artificial intelligence-estimated electrocardiographic sex as a recurrence predictor after atrial fibrillation catheter ablation
| EUROPEAN HEART JOURNAL - DIGITAL HEALTH |
| 2025 | Associations of accelerometer-derived moderate-to-vigorous physical activity and atrioventricular block in a healthy elderly population | HEART RHYTHM |
| 2025 | Proteomic Signatures for Risk Prediction of Atrial Fibrillation | CIRCULATION |
| 2025 | Temporal trends in ischemic stroke and female sex as a risk modifier in atrial fibrillation: insights from non-anticoagulated Asian patients in a nationwide cohort study
| LANCET REGIONAL HEALTH-WESTERN PACIFIC |
| 2025 | Optimizing outcomes: adherence to the ABC (Atrial fibrillation Better Care) pathway in Asian atrial fibrillation patients with chronic kidney disease
| LANCET REGIONAL HEALTH-WESTERN PACIFIC |
| 2025 | Long-Acting Factor XI Inhibition and Periprocedural Bleeding : An Analysis From AZALEA-TIMI 71 | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
| 2025 | Safety and Performance of the Micra VR Leadless Pacemaker in a South Korean Cohort: A Comparison to Global Studies
| KOREAN CIRCULATION JOURNAL |
| 2025 | Metabolic Status and Atrioventricular Block Risk: The Role of Physical Activity
| REVIEWS IN CARDIOVASCULAR MEDICINE |
| 2025 | Integration of Left Atrial Function Assessment, Genetic Risk, and Clinical Risk Factors Improves Prediction of Incident Atrial Fibrillation | JOURNAL OF THE AMERICAN HEART ASSOCIATION |
| 2025 | Early Rhythm Control for Atrial Fibrillation in Patients With End-Stage or Chronic Kidney Disease | MAYO CLINIC PROCEEDINGS |
| 2025 | Polygenic Risk and Cardiovascular Event Risk in Patients With Atrial Fibrillation With Low to Intermediate Stroke Risk
| JOURNAL OF THE AMERICAN HEART ASSOCIATION |
| 2025 | Pathogenic KCNH2-G53S variant in the PAS domain influences the electrophysiological phenotype in long QT syndrome type 2
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2025 | Tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy
| EUROPACE |
| 2025 | Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration | CIRCULATION |
| 2025 | Injured Cardiac Tissue-Targeted Delivery of TGFβ1 siRNA by FAP Aptamer-Functionalized Extracellular Vesicles Promotes Cardiac Repair
| INTERNATIONAL JOURNAL OF NANOMEDICINE |
| 2025 | Clinical and Genetic Risk Factors Predict Atrial Fibrillation on the Basis of Hypertrophic Cardiomyopathy
| JOURNAL OF THE AMERICAN HEART ASSOCIATION |
| 2025 | Artificial intelligence-derived electrocardiographic aging and risk of atrial fibrillation: a multi-national study | EUROPEAN HEART JOURNAL |
| 2025 | Clinical outcomes of Asian patients with newly diagnosed atrial fibrillation and previously diagnosed atrial fibrillation: Insights from the CODE-AF Registry | HEART RHYTHM |
| 2025 | Extended Period Outcomes of Posterior Box Isolation in 4 Randomized Atrial Fibrillation Catheter Ablation Trials
| JACC: Asia |
| 2025 | Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation | NEW ENGLAND JOURNAL OF MEDICINE |
| 2025 | Cryoballoon Pulmonary Vein Isolation With Versus Without Additional Right Atrial Linear Ablation for Persistent Atrial Fibrillation: The CRALAL Randomized Clinical Trial | CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY |
| 2024 | Novel algorithm for non-invasive estimation of left atrial pressure in patients with atrial fibrillation | EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING |
| 2024 | Establishment of a human-induced pluripotent stem cell line from a long QT syndrome type 2 patient harboring a KCNH2 mutation | STEM CELL RESEARCH |
| 2024 | Establishment of two human induced pluripotent stem cell lines from familial long QT syndrome type 1 patients carrying KCNQ1 mutation | STEM CELL RESEARCH |
http://orcid.org/0000-0001-9036-7225
(6508263919)
